Mark Yockey, MD
Urology · Orlando, FLNPI 1326239203
Payments from drug & device makers
Across 119 payments — averaging $67.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Verathon Inc.$2K
- Gyrus ACMI, Inc.$2K
- Medtronic$1K
- Olympus Winter & Ibe GmbH$875
- Astellas Pharma US Inc$512
- Pfizer$324
- plus $2K from 26 others
What the payments were for
- Consulting fees$3,88048%
- Speaking & faculty fees$1,80022%
- Travel & lodging$150%
- Food & beverage$2,31629%
- Education$761%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Verathon Inc. | 1 | $2,000 |
| Gyrus ACMI, Inc. | 2 | $1,815 |
| Medtronic(2 entities) | 5 | $1,050 |
| Olympus Winter & Ibe GmbH | 1 | $875 |
| Astellas Pharma US Inc | 25 | $512 |
| Pfizer | 19 | $324 |
| Neotract Inc. | 3 | $235 |
| Myovant Sciences Inc. | 8 | $135 |
| Endo Pharmaceuticals Inc. | 7 | $131 |
| AbbVie(2 entities) | 9 | $130 |
| Teleflex LLC | 1 | $106 |
| C. R. Bard, Inc. & Subsidiaries | 5 | $105 |
| Johnson & Johnson | 5 | $84 |
| Bayer | 4 | $73 |
| 180 Medical, Inc. | 2 | $52 |
| Amgen | 3 | $51 |
| Rochester Medical Corporation | 2 | $50 |
| Procept Biorobotics Corporation | 2 | $47 |
| Antares Pharma, Inc. | 2 | $36 |
| Accord Healthcare, Inc. | 1 | $35 |
| Boston Scientific | 1 | $31 |
| Olympus America Inc. | 1 | $28 |
| Myriad Genetic Laboratories, Inc. | 1 | $25 |
| Coloplast | 1 | $19 |
| Smith+Nephew | 1 | $19 |
| Verity Pharmaceuticals Inc. | 1 | $19 |
| Clarus Therapeutics Inc. | 1 | $18 |
| Acerus Pharmaceuticals Corporation | 1 | $18 |
| Cycle Pharmaceuticals Inc | 1 | $18 |
| Laborie Medical Technologies Corp. | 1 | $16 |
| Mission Pharmacal Company | 1 | $15 |
| Sumitomo Pharma America, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NPD Clinical Study$2,000
- ENDOEYE FLEX DEFLECTABLE VIDEOSCOPE$875
- INTERSTIM$355
- UroLift$123
- UroLift System$106
How this compares
$8,088 in reported general payments places this provider in the 65th percentile of 935 urology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 32 | $1,150 |
| Finasteride | 15 | $247 |
| Levofloxacin | 25 | $50 |
Paid to pharmacies, not to this prescriber.
Other urology in Orlando
- Lucas WiegandOrlando$587K
- Olubayo TojuolaOrlando$283K
- Inoel Rivera-RamirezOrlando$277K
- Jeffrey BradyOrlando$164K
- Steven KesterPompano Beach$5.7M
- Harvey SamowitzHallandale Beach$3.6M
- Paul PeritoCoral Gables$3.6M
- Graham GreeneLakeland$2.5M
- Scott SellingerTallahassee$2.3M
- Fernando BiancoHialeah$2.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.